Clinical trial
An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus…
NCT00094770 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00094770 |
|---|---|
| Title | An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024) |
| Official title | A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of MK0431 Compared With Sulfonylurea Therapy in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Metformin Monotherapy |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | sitagliptin (MK0431), Comparator: glipizide |
| Enrollment | 1,172 |
| Start date | Sep 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Oct 25, 2004 |
| Last update posted | Aug 26, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: